In understanding English, as long as you know "what kind of arguments a verb requires," there is no need to formally label the following noun as an object or a complement. Distinguishing between SVO ...
Drawn from the UB Poetry Collection and UB Art Galleries Collection in celebration of Creeley’s centenary year, this exhibition explores Robert Creeley’s various approaches to collaborative artmaking, ...
When containers started out, they were meant to be ephemeral – stateless, disposable and data-light. But that’s all changed. As Gartner notes, use cases for containers have evolved to include ...
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Against this backdrop, the ...
There has been some originalist debate of late about the proper reading of the Citizenship Clause of the Fourteenth Amendment. The fate of the Trump administration's executive order excluding new ...
It’s been 250 years since the signing of the Declaration of Independence — a milestone that invites not just celebration, but reflection. To illustrate two and a half centuries of U.S. history, Here & ...
A replica pipe bomb discovered in a passenger’s checked bag at Boise Airport (BOI) topped the Transportation Security Administration’s (TSA) Top 10 list of most unusual items detected at U.S. airport ...
CTx001, a gene therapy for geographic atrophy, received FDA Fast Track Designation, expediting its development and review process. The Opti-GAIN phase 1/2 trial will assess CTx001's safety, ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results